Fingerprinting the diseased prostate: Associations between BPH and prostate cancer

Two of the most common diseases which occur in ageing men relate to their prostate. BPH and prostate cancer are prevalent diseases which have an impact on most men as they age. The advent of gene expression analysis has provided an opportunity to examine these diseases in a novel fashion. These analyses, to date, have revealed associations between these two diseases which have not been previously identified. These commonalities include global genetic changes which occur throughout the prostates in individuals with these diseases. Understanding the fingerprints of these diseases is providing novel markers and treatment strategies for both BPH and prostate cancer. © 2003 Wiley‐Liss, Inc.

[1]  E. Giovannucci.  Epidemiologic Characteristics of Prostate Cancer , 1995 .

[2]  J. Schrader,et al.  Ras and relatives--job sharing and networking keep an old family together. , 2002, Experimental hematology.

[3]  Manel Esteller,et al.  Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer. , 2002, Cancer research.

[4]  T. Sasagawa,et al.  Reduction in the local expression of complement component 6 (C6) and 7 (C7) mRNAs in oesophageal carcinoma. , 2001, European journal of cancer.

[5]  E. Kranias,et al.  Structure and expression of the mouse cardiac calsequestrin gene , 2001, Basic Research in Cardiology.

[6]  Hiroshi Wachi,et al.  Domains in Tropoelastin That Mediate Elastin Depositionin Vitro and in Vivo * , 2003, The Journal of Biological Chemistry.

[7]  S. Ognjanovic,et al.  Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. , 2002, American journal of obstetrics and gynecology.

[8]  T. Barrette,et al.  Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. , 2002, Cancer research.

[9]  D. Perry,et al.  Cloning of interferon-stimulated gene 17: the promoter and nuclear proteins that regulate transcription. , 1999, Molecular endocrinology.

[10]  R. Dhir,et al.  Symptomatic and asymptomatic benign prostatic hyperplasia: Molecular differentiation by using microarrays , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  W. G. Roper.  The etiology of benign prostatic hypertrophy. , 1998, Medical hypotheses.

[12]  C. Montell,et al.  Retinal Targets for Calmodulin Include Proteins Implicated in Synaptic Transmission* , 1998, The Journal of Biological Chemistry.

[13]  N. Kanaya,et al.  Propofol Increases Phosphorylation of Troponin I and Myosin Light Chain 2 via Protein Kinase C Activation in Cardiomyocytes , 2003, Anesthesiology.

[14]  U. Scherf,et al.  Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling , 2001, Cancer.

[15]  F. S. French,et al.  Immunohistochemical localization of the androgen receptor in rat and human tissues. , 1990, Endocrinology.

[16]  O. Cussenot,et al.  Androgens are not a direct requirement for the proliferation of human prostatic epithelium in vitro , 1997, International journal of cancer.

[17]  J. Baik,et al.  Expression of Angiogenic Factor Cyr61 during Neuronal Cell Death via the Activation of c-Jun N-terminal Kinase and Serum Response Factor* , 2003, The Journal of Biological Chemistry.

[18]  N. Tørring,et al.  Quantitation of the mRNA expression of the epidermal growth factor system: selective induction of heparin-binding epidermal growth factor-like growth factor and amphiregulin expression by growth factor stimulation of prostate stromal cells. , 2000, The Journal of laboratory and clinical medicine.

[19]  A. Whittemore,et al.  Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. , 1995, American journal of epidemiology.

[20]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[21]  C. Acquaviva,et al.  Multiple Degradation Pathways for Fos Family Proteins , 2002, Annals of the New York Academy of Sciences.

[22]  Taylor Murray,et al.  Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.

[23]  C. Beaudry,et al.  Identification and validation of P311 as a glioblastoma invasion gene using laser capture microdissection. , 2001, Cancer research.

[24]  M. Zannini,et al.  The Paired Domain-containing Factor Pax8 and the Homeodomain-containing Factor TTF-1 Directly Interact and Synergistically Activate Transcription* , 2003, The Journal of Biological Chemistry.

[25]  L. Kolonel.  Fat, meat, and prostate cancer. , 2001, Epidemiologic reviews.

[26]  R. Timpl,et al.  Proteinases of the Bone Morphogenetic Protein-1 Family Convert Procollagen VII to Mature Anchoring Fibril Collagen* , 2002, The Journal of Biological Chemistry.

[27]  P. Roughley,et al.  Lumican is a major proteoglycan component of the bone matrix. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[28]  S. Yamada,et al.  Structure and promoter activity of the gene encoding ornithine decarboxylase antizyme expressed exclusively in haploid germ cells in testis (OAZt/Oaz3). , 2002, Gene.

[29]  J. Regan,et al.  Prostaglandin E2 Induced Functional Expression of Early Growth Response Factor-1 by EP4, but Not EP2, Prostanoid Receptors via the Phosphatidylinositol 3-Kinase and Extracellular Signal-regulated Kinases* , 2003, The Journal of Biological Chemistry.

[30]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[31]  C. Lee,et al.  Role of androgen in prostate growth and regression: Stromal‐epithelial interaction , 1996, The Prostate. Supplement.

[32]  Y. Wong,et al.  Growth factors and epithelial-stromal interactions in prostate cancer development. , 2000, International review of cytology.

[33]  G. Krystal,et al.  Early events in erythropoietin-induced signaling. , 1996, Experimental hematology.

[34]  E. Milgrom,et al.  JAB1 Interacts with Both the Progesterone Receptor and SRC-1* , 2000, The Journal of Biological Chemistry.

[35]  P. Herrero,et al.  Mediator factor Med8p interacts with the hexokinase 2: implication in the glucose signalling pathway of Saccharomyces cerevisiae. , 2002, Journal of molecular biology.

[36]  A. Gressner,et al.  LIM-domain protein cysteine- and glycine-rich protein 2 (CRP2) is a novel marker of hepatic stellate cells and binding partner of the protein inhibitor of activated STAT1. , 2001, The Biochemical journal.

[37]  J. Oesterling,et al.  Benign prostatic hyperplasia: A review of its histogenesis and natural history , 1996, The Prostate. Supplement.

[38]  P. Scott,et al.  Light and X-ray Scattering Show Decorin to Be a Dimer in Solution* , 2003, The Journal of Biological Chemistry.

[39]  T. Pihlajaniemi,et al.  Lack of cytosolic and transmembrane domains of type XIII collagen results in progressive myopathy. , 2001, The American journal of pathology.

[40]  P. Flores-Villanueva,et al.  Linkage disequilibrium between HLA-DPB1 alleles and retinoid X receptor β haplotypes , 2002 .

[41]  P. Burrows,et al.  The neuronal EGF-related genes NELL1 and NELL2 are expressed in hemopoietic cells and developmentally regulated in the B lineage. , 1999, Gene.

[42]  B. Neubauer,et al.  Epithelial-mesenchymal interactions in prostatic development. II. Biochemical observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder , 1983, The Journal of cell biology.

[43]  D. S. Coffey,et al.  New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia. , 1999, Urology.

[44]  Michael J. Wilson,et al.  Expression of matrix metalloproteinase‐2 and ‐9 and their inhibitors, tissue inhibitor of metalloproteinase‐1 and ‐2, in primary cultures of human prostatic stromal and epithelial cells * † , 2002, Journal of cellular physiology.

[45]  M. Spurlock,et al.  Expression and complement d activity of porcine adipsin. , 2001, Protein expression and purification.

[46]  D. Lockhart,et al.  Expression monitoring by hybridization to high-density oligonucleotide arrays , 1996, Nature Biotechnology.

[47]  Jason G. Cyster,et al.  A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1 , 1998, Nature.